| Literature DB >> 24192426 |
Karin Bölenius1, Marie Lindkvist, Christine Brulin, Kjell Grankvist, Karin Nilsson, Johan Söderberg.
Abstract
BACKGROUND: Phlebotomy performed with poor adherence to venous blood specimen collection (VBSC) guidelines jeopardizes patient safety and may lead to patient suffering and adverse events. A first questionnaire study demonstrated low compliance to VBSC guidelines, motivating an educational intervention of all phlebotomists within a county council. The aim was to evaluate the impact of a large-scale educational intervention program (EIP) on primary health care phlebotomists' adherence to VBSC guidelines. We hypothesised that the EIP would improve phlebotomists' VBSC practical performance.Entities:
Mesh:
Year: 2013 PMID: 24192426 PMCID: PMC4228245 DOI: 10.1186/1472-6963-13-463
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Numbers of IG personnel participating in the intervention over time
| 200909 | 9 | - | - | 8 | - | - | 17 |
| 200910 | 1 | - | - | - | - | - | 1 |
| 200911 | 5 | 1 | - | 1 | - | - | 7 |
| 200912 | - | 6 | - | - | - | - | 6 |
| 201001 | - | 5 | - | - | 1 | - | 6 |
| 201002 | - | 1 | - | - | 1 | - | 2 |
| 201003 | - | - | - | - | 2 | 15 | 17 |
| 201004 | - | - | - | 4 | 1 | - | 5 |
| 201005 | - | - | - | - | - | 4 | 4 |
| 201006 | - | - | - | 3 | - | 1 | 4 |
| 201007 | - | - | - | 2 | 5 | - | 7 |
| 201008 | - | - | - | - | - | - | 0 |
| 201009 | - | - | - | - | - | - | 0 |
| 201010 | - | - | - | - | - | - | 0 |
| 201011 | - | - | 1 | - | - | 7 | 8 |
| Total | 15 | 13 | 1 | 18 | 10* | 27* | 84 |
PHCs 1–4 are urban and PHCs 11–17 rural, all connected to a university hospital. PHCs 5–9 urban and PHCs 18–24 rural connected to a hospital 140 km north of the university hospital. PHC 10 is urban and PHCs 25–31 rural and connected to a hospital 130 km west of the university hospital.
* = 27/84 participated by internet link.
Figure 1The flow chart shows the staff invited to join the study.
Baseline characteristics of the participants
| | | | |
| Female n | 79 | 79 | 0.059* |
| Male n | 5 | 0 | |
| | | | |
| Registered nurses n | 26 | 50 | <0.001* |
| Enrolled nurses n | 56 | 28 | |
| Biomedical technician n | 2 | 1 | |
| | | | |
| Age Md (Q1; Q3) | 55 (49; 60) | 56 (49; 62) | 0.604″ |
| Range | 28-65 | 38-70 | |
| | | | |
| Md (Q1; Q3) | 11 (7; 27) | 11 (5; 20) | 0.045″ |
| Range | 0-37 | 0-38 | |
| | | | |
| Every day n | 61 | 44 | 0.028* |
| Every week n | 19 | 33 | |
| Every month or less n | 4 | 2 |
IG = Intervention group, CG = Control group, p = differences at baseline between IG and CG, * = Chi-square Test, ″ = Mann–Whitney U Test.
Changes in self-reported adherence to VBSC guidelines
| | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| | | | | | | | | | | | |
| 7a Ask for name and identification number (4) | 0.232 | 3.5/4 | 80 | 0.026 | .18 | 4/4 | 79 | 0.016 | .19 | 0.471 | .06 |
| 7b I already know the patient (1) | 0.380 | 2/1.5 | 79 | 0.019 | .19 | 2/2 | 77 | 0.048 | .16 | 0.028 | .01 |
| 7d Control of patient’s photo-ID (4) | 1/2 | 79 | .34 | 2/2 | 77 | 0.048 | .16 | 0.028 | .18 | ||
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| 8a -before first sample is drawn (4) | 0.785 | 3/3 | 77 | 0.060 | .15 | 2/3 | 75 | 0.805 | .02 | 0.287 | .09 |
| 8b -during sampling (4) | 0.868 | 3/3 | 76 | 0.538 | .05 | 3/3 | 74 | 0.043 | .17 | 0.285 | .09 |
| 8c -when finished sampling (1) | 0.997 | 2/1 | 75 | .22 | 2/2 | 71 | 1.000 | 0 | 0.040 | .17 | |
| 8d Keep stasis as long as necessary (1) | 0.789 | 3/2 | 76 | 0.019 | .19 | 3/3 | 73 | 0.886 | .01 | 0.144 | .15 |
| | | | | | | | | | | | |
| 10a -invert the test tube immediately (4) | 0.641 | 4/4 | 82 | 0.021 | .18 | 4/4 | 78 | 0.063 | .15 | 0.600 | .04 |
| 10b -use automated reverser (4) | 0.403 | 4/4 | 82 | 0.228 | .09 | 3/4 | 74 | 0.016 | .20 | 0.446 | .06 |
| | | | | | | | | | | | |
| 11a Use outdated printed sampling instructions (1) | 2/1 | 78 | .31 | 1/1 | 73 | 0.415 | .07 | .32 | |||
| 11b Check updated information in updated internet network (4) | 3.5/4 | 78 | .37 | 4/4 | 78 | 1.000 | 0 | .33 | |||
| 11d Ask colleagues for information (1) | 3/2 | 81 | .30 | 2/2 | 74 | 1.000 | 0 | .23 | |||
| 11f Call the laboratory for information (1) | 0.327 | 2/2 | 78 | .21 | 2/2 | 74 | 1.000 | 0 | 0.046 | .16 | |
| | | | | | | | | | | | |
| 12a -lying on work-bench (1) | 0.159 | 1/1 | 75 | 0.518 | .05 | 1/1 | 71 | 0.181 | .11 | 0.535 | .05 |
| 12b -in the pocket (1) | 0.307 | 1/1 | 74 | 0.083 | .14 | 1/1 | 71 | 0.317 | .08 | 0.049 | .16 |
| 12c -in a test tube stand (4) | 0.796 | 4/4 | 80 | 0.357 | .07 | 4/4 | 77 | 0.130 | .12 | 0.084 | .14 |
| | | | | | | | | | | | |
| 13 How often someone else marks the sampling time (5) | 0.371 | 5/5 | 83 | 0.227 | .09 | 5/5 | 79 | 0.443 | .09 | 0.951 | .01 |
| 15a Compare identification number with test request (4) | 0.344 | 4/4 | 82 | 0.847 | .01 | 4/4 | 79 | 0.132 | .12 | 0.426 | .06 |
| 15c Sign the test request (4) | 0.713 | 4/4 | 82 | 0.152 | .11 | 4/4 | 76 | 0.021 | .19 | .22 | |
| 15d Check information if somebody else has completed it (4) | 0.165 | 4/4 | 81 | 0.054 | .15 | 4/4 | 79 | 0.185 | .11 | 0.444 | .06 |
| 15e Adjust sampling time if marked time differs from sampling time (4) | 0.176 | 3/4 | 78 | 0.095 | .13 | 4/4 | 76 | 0.519 | .05 | 0.558 | .05 |
| 15f Check that test request and test tube identification (barcode) numbers match (4) | 4/4 | 83 | .23 | 4/4 | 77 | 0.961 | 0 | 0.012 | .20 | ||
| | | | | | | | | | | | |
| 16a -before approaching the patient (1) | 0.461 | 1/1 | 79 | 0.092 | .25 | 1/1 | 71 | 0.567 | .05 | 0.740 | .03 |
| 16b -at patient’s side prior to sampling (4) | 2/3 | 80 | .49 | 1/1 | 72 | 0.045 | .17 | 0.060 | .16 | ||
| 16c -at patient’s side, after sampling (4) | 4/3 | 80 | 0.104 | .10 | 4/4 | 77 | 0.032 | .17 | 0.919 | .01 | |
| 16d -at a later occasion (1) | 0.076 | 1/1 | 79 | 0.052 | .01 | 1/1 | 70 | 0.132 | .13 | 0.019 | .20 |
| 16e Somebody else labelled in advance (1) | 0.017 | 1/1 | 80 | 0.405 | .07 | 1/1 | 71 | 0.257 | .10 | 0.181 | .11 |
| 16f Somebody else labels after sampling (1) | 0.246 | 1/1 | 80 | 0.096 | .27 | 1/1 | 71 | 0.564 | .05 | 0.173 | .11 |
| | | | | | | | | | | | |
| 19a I have enough knowledge for my daily work (3) | 0.483 | 2/3 | 83 | .34 | 2/3 | 79 | 0.059 | .15 | 0.075 | .14 | |
| 19b Proper VBSC is considered a priority at my PHC (3) | 0.235 | 2/3 | 81 | 0.034 | .17 | 3/3 | 78 | 0.760 | .02 | 0.082 | .14 |
P = Mann-Witney U Test, between IG and CG at baseline.
P2 = Wilcoxon Signed Rank Test, within IG and CG.
P3 = Mann-Witney U Test, for changes between IG and CG, IG = Intervention group, CG = Control group.
Significant improvement = p < 0.01, marked with bold font.
ES1 = Effect size measured by Z/n*2 square, ES2 = 0045ffect size measured by Z/n square.
Md = Median self-reported answers on a scale where either 1 or 4 is often the best possible answer. Desirable result is shown within parenthesis for each item.
Changes in self-reported adherence to VBSC guidelines
| | | | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 Always allow the patient to rest 11- >15 minutes prior to specimen collection | 0.840 | 21/37 | 80 | 0.54 | 30/23 | 76 | 0.405 | 0.24 | 0.27 | ||
| 14 Always write in sampling time (0–30 minutes after sampling) | 0.233 | 45/51 | 84 | 0.405 | 0.46 | 51/64 | 77 | 0.064 | .39 | 0.687 | 0.07 |
p = Between IG and CG at baseline.
p2 = McNemar, (within IG and CG).
p3 = Chi-square for independence (between IG and CG), IG = Intervention group, CG = Control group.
Significant improvement = p < 0.01 marked with bold font. Significant improvement = p < 0.01 because of repeated tests. Effect size measured by Cramer’s V.
% = Percentage of correct answer.